UCI launches effort to develop patient-specific stem cell linesMay 15, 2007UC Irvine neurobiologist Hans Keirstead and his research team today launched a project to develop stem cell lines that genetically match human patients. These lines would allow scientists to better study conditions ranging from diabetes to Parkinson's disease, and they would provide the basis for potential patient-specific stem cell treatments. Keirstead will use a technique called somatic cell nuclear transfer (SCNT) in which a patient's DNA is transplanted into a donated unfertilized egg cell in order to generate stem cell lines with the same genetic makeup of the patient. These lines have tremendous therapy potential because the human immune system is less likely to attack genetically identical cells. Only a few laboratories in the world are attempting this technique in human stem cell research and, thus far, no human stem cell lines have been derived using this method. "This technique holds tremendous promise to advance our knowledge of stem cells and their potential to cure disease," said Keirstead, associate professor of anatomy and neurobiology and co-director of UCI's Sue and Bill Gross Stem Cell Research Center. "I am excited to embark on this line of research and look forward to the day when patient-specific stem cells are utilized to treat people suffering from debilitating injuries and health conditions."
This project received approval May 11 from UCI's Institutional Review Board, which under federal regulation reviews all proposed studies involving human tissue. The Embryonic Stem Cell Research Oversight Committee at UCI also has reviewed the project and will ensure that experiments involving embryonic stem cells serve important research goals and are conducted according to the highest ethical standards. UCI has built a cutting-edge workstation that is custom-designed for SCNT experiments. Designed by Gabriel Nistor, a scientist in Keirstead's laboratory, the quarter-million dollar system housed at the Sue and Bill Gross Stem Cell Research Center will allow scientists to dissect single cells using lasers, manipulate cells using robotic instruments, and control the climate in the work area. Nistor collaborated with scientists at West Coast Fertility Centers' Embryology Laboratory to design the system. From this Orange County medical practice, Keirstead plans to obtain donated egg cells for his SCNT research. Stem cells are the "master" cells that give rise to each of the specialized cells within the human body. During organ and tissue development, these cells transform into a particular specialized cell, such as a heart cell or a liver cell, when prompted by their environment or by their internal genetic programming. If researchers can control the processes directing stem cell transformation, they may one day be able to use these cells as a source of healthy replacement cells for diseased or injured tissues. Keirstead is a pioneer in the use of human embryonic stem cells in the study of spinal cord injuries. Keirstead's laboratory was the first in the world to develop a method to restrict human embryonic stem cells so they generate large amounts of only one cell type in high purity. That type of cell, an oligodendrocyte, insulates connections in the spinal cord, allowing them to conduct electricity. University of California, Irvine | |||||||||||||||||||||
|
Related Stem Cell Current Events and Stem Cell News Articles Mayo researchers explore issues related to multiple myeloma treatment Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Emerging model organisms featured in CSH Protocols Biological research has long relied on a small number of model organisms, species chosen because they are amenable to laboratory research and suitable for the study of a range of biological problems. Reversible 3-D cell culture gel invented Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research. What to do with leftover embryos in fertility clinics? The majority of infertility patients are in favor of using left-over embryos for stem cell research and would also support selling left-over embryos to other couples, according to a recent survey. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle. Stem cells may solve mystery of early pregnancy breast cancer protection The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell. Scientists identify genes capable of regulating stem cell function Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders. Embryonic stem cells might help reduce transplantation rejection Researchers have shown that immune-defense cells influenced by embryonic stem cell-derived cells can help prevent the rejection of hearts transplanted into mice, all without the use of immunosuppressive drugs. Stem cell regeneration repairs congenital heart defect Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. OU Cancer Institute Scientists Identify New Cancer Stem Cell Marker; Developing Drug to Stop Cancer Recurrence After years of working toward this goal, scientists at the OU Cancer Institute have found a way to isolate cancer stem cells in tumors so they can target the cells and kill them, keeping cancer from returning. More Stem Cell Current Events and Stem Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||